Rieke J W, Kapp D S
Department of Therapeutic Radiology, Stanford University School of Medicine, California 94305.
Gynecol Oncol. 1988 Oct;31(2):338-51. doi: 10.1016/s0090-8258(88)80013-1.
Malignant pericardial effusion secondary to pericardial metastases from gynecological malignancies represents an infrequent but potentially life threatening problem. A patient with recurrent squamous cell carcinoma of the cervix causing symptomatic pericardial effusion is presented, and the incidence, mechanism, pathophysiology, treatment, and outcomes of malignant pericardial effusion in patients with gynecologic malignancies are reviewed. This case represents only the fourth reported patient with metastatic carcinoma of the cervix in whom the diagnosis of malignant pericardial effusion was made antemortem, and is the longest survivor of treatment. Gratifying results, in terms of improved quality and length of survival, can be obtained in what is often perceived as a preterminal complication. Recommendations for management are presented, stressing radiation therapy and other local measures following initial pericardiocentesis.
继发于妇科恶性肿瘤心包转移的恶性心包积液是一个罕见但可能危及生命的问题。本文介绍了一名复发性宫颈鳞状细胞癌导致有症状心包积液的患者,并对妇科恶性肿瘤患者恶性心包积液的发病率、机制、病理生理学、治疗及预后进行了综述。该病例是第四例生前诊断为恶性心包积液的宫颈转移癌患者报告,也是治疗后存活时间最长的患者。对于这种常被视为终末期前并发症的疾病,通过改善生存质量和延长生存期可以获得令人满意的结果。文中给出了管理建议,强调在初次心包穿刺后进行放射治疗及其他局部治疗措施。